Abstract:HIV protease inhibitor (PI)-induced diarrhea is one of the most frequent adverse side effects of these drugs and occurs in 16 to 62% of patients.Recently it has been reported that HIV PIs induce apoptosis and decrease barrier function in intestinal epithelial cells.However, the underlying cellular/molecular mechanisms remain unclear.We have previously demonstrated that HIV PIs induce endoplasmic reticulum (ER) stress, activate the unfolded protein response (UPR), and promote apoptosis in macrophages and hepatocytes.In the present study, we examined whether HIV PI-induced ER stress also plays a role in HIV PI-induced apoptosis and disruption of barrier function in intestinal epithelial cells.Methods: In Vitro studies were conducted in IEC6 cells (normal rat intestinal epithelial cells), differentiated IEC6 (stable Cdx2-transfected, IEC6-Cdx2L1), and stable SEAP-transfected IEC6 cells.HIV PIinduced ER stress was measured by decrease of SEAP activity.The mRNA and protein expression levels of ER stress-related genes were determined by real-time RT-PCR and western blot analysis, respectively.The paracellular permeability was measured by paracellular tracer flux assay and membrane-impermeable molecule, [14C]-mannitol, served as tracer.Lentiviral CHOP siRNA was used to knock down CHOP expression in IEC6 cells.Both C57/B6 wild type and CHOP knock out mice were used in In Vivo studies.Mice were gavaged with individual HIV PI (50 mg/kg) for three weeks.The pathological changes in intestine and colon were determined by histological evaluation.Results: Both ritonavir and lopinavir significantly induced ER stress, increased the expression of GRP78, CHOP, XBP-1 and ATF4, and promoted apoptosis in IEC6 and IEC6-Cdx2L1 cells.Paracellular permeability was increased by ~2.5 to 5 fold after cells were treated with 15 µM of ritonavir or lopinavir for 24 h.In contrast, amprenavir neither induced ER stress, nor increased paracellular permeability.Down-regulation of CHOP expression in IEC6 cells reduced HIV PI-induced apoptosis and disruption of barrier function.In Vivo studies demonstrated that ritonavir and lopinavir also significantly induced CHOP, XBP-1 and ATF4 expression in the intestine and colon of wild type mice.Furthermore, histological assessment indicated that ritonavir and lopinavir significantly induced intestinal epithelial damage in wild type mice, but had less effect in CHOP knock out mice.Conclusions: These findings indicate that HIV PI-induced ER stress and subsequent activation of the UPR represents an important cellular/molecular mechanism underlying HIV PI-induced disruption of intestinal barrier function.

PPARγ downregulation in colonic CD8+ T cells results in epithelial barrier disruption in people with HIV on antiretroviral therapy

Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients

PPARα-targeted mitochondrial bioenergetics mediate repair of intestinal barriers at the host-microbe intersection during SIV infection

Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection

Gut epithelial barrier and systemic inflammation during chronic HIV infection

Markers of Gut Barrier Function and Microbial Translocation Associate with Lower Gut Microbial Diversity in People with HIV

Irreversible depletion of intestinal CD4+ T cells is associated with T cell activation during chronic HIV infection

Novel Immunological Markers of Intestinal Impairment Indicative of HIV-1 Status and/or Subclinical Atherosclerosis

W1269 HIV Protease Inhibitors Induce ER Stress and Disrupt Barrier Function in Intestinal Epithelial Cells

Major depletion of insulin sensitivity-associated taxa in the gut microbiome of persons living with HIV controlled by antiretroviral drugs

Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing antiretroviral therapy

HIV Protease Inhibitors Induce Endoplasmic Reticulum Stress and Disrupt Barrier Integrity in Intestinal Epithelial Cells

Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: an Observational Study in A Chinese Population

miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARγ and Occludin Expression in Chronic Simian Immunodeficiency Virus-Infected Rhesus Macaques

Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection

Antiretroviral Therapy Dampens Mucosal CD4+ T Lamina Propria Lymphocytes Immune Activation in Long-Term Treated People Living with HIV-1

Brief Report: Inflammatory Colonic Innate Lymphoid Cells Are Increased During Untreated HIV-1 Infection and Associated With Markers of Gut Dysbiosis and Mucosal Immune Activation

Microbial exposure alters HIV-1-induced mucosal CD4+ T cell death pathways Ex vivo

Impaired gut microbiota-mediated short-chain fatty acid production precedes morbidity and mortality in people with HIV

Gut Microbiome Changes Associated with Epithelial Barrier Damage and Systemic Inflammation during Antiretroviral Therapy of Chronic SIV Infection

Altered mucosal immunity in HIV-positive colon adenoma: decreased CD4+ T cell infiltration is correlated with nadir but not current CD4+ T cell blood counts